Your browser doesn't support javascript.
loading
A Community-Driven Framework to Prioritize the Use of Donated Human Biological Materials in the Context of HIV Cure-Related Research at the End of Life.
Dubé, Karine; Villa, Thomas J; Taylor, Jeff; Kaytes, Andy; Moore, David J; Little, Susan J; Chaillon, Antoine; Smith, Davey M; Gianella, Sara.
Afiliación
  • Dubé K; Division of Infectious Diseases and Global Public Health, School of Medicine, University of California San Diego, La Jolla, CA.
  • Villa TJ; AntiViral Research Center, University of California San Diego, San Diego, CA.
  • Taylor J; Health Policy and Management, UNC Gillings School of Global Public Health, Chapel Hill, NC.
  • Kaytes A; HIV Obstruction by Programmed Epigenetics Delaney Collaboratory Community Team, San Francisco, CA.
  • Moore DJ; Reversing Immune Dysfunction Delaney Collaboratory for HIV Cure Research Community Advisory Board, La Jolla, CA.
  • Little SJ; Reversing Immune Dysfunction Delaney Collaboratory for HIV Cure Research Community Advisory Board, La Jolla, CA.
  • Chaillon A; HIV + Aging Research Project - Palm Springs, Palm Springs, CA.
  • Smith DM; AntiViral Research Center Community Advisory Board, University of California San Diego, San Diego, CA.
  • Gianella S; Reversing Immune Dysfunction Delaney Collaboratory for HIV Cure Research Community Advisory Board, La Jolla, CA.
Pathog Immun ; 8(1): 1-16, 2023.
Article en En | MEDLINE | ID: mdl-37252012
Initiated in 2017 after extensive community engagement, the Last Gift program enrolls altruistic volunteers willing to donate their cells and tissues at the end of life to allow studies on HIV reservoir dynamics across anatomical sites. As the Last Gift team received tissue requests outside the scope of HIV cure research, we noticed the absence of guiding frameworks to help prioritize the use of altruistically donated human biological materials. In this commentary, we present a proposed framework for prioritizing the use of donated human biological materials within and outside the end-of-life (EOL) HIV cure research context, using the Last Gift study as an example. First, we discuss regulatory and policy considerations, and highlight key ethical values to guide prioritization decisions. Second, we present our prioritization framework and share some of our experiences prioritizing requests for donated human biological materials within and outside EOL HIV cure research.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Pathog Immun Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Pathog Immun Año: 2023 Tipo del documento: Article